(Q41353105)

29 September 2017

1 reference

title

Role of natural killer cells in innate resistance to protozoan infections (English)

1 reference

29 September 2017

Scharton-Kersten TM

1

1 reference

PubMed ID

9039777

29 September 2017

Sher A

series ordinal

2

1 reference

29 September 2017

1 February 1997

1 reference

Current Opinion in Immunology

29 September 2017

1 reference

29 September 2017

9

1 reference

29 September 2017

44-51

1 reference

29 September 2017

1

1 reference

The role of natural killer cells in host-parasite interactions

29 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

The role of the innate immune response in Th1 cell development following Leishmania major infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

The role of natural killer cells in innate resistance to infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Differences in susceptibility of various mouse strains to haemoprotozoan infections: possible correlation with natural killer activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

The role of natural killer cells in resistance to coccidiosis: investigations in a murine model.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Leishmaniasis in beige mice

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Proliferation of Theileria annulata and Theileria parva macroschizont-infected bovine cells in scid mice

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Natural killer cells induced by acute and chronic toxoplasma infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Destruction of Trypanosoma cruzi by Natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Cytotoxicity of human natural killer (NK) cell subsets for Plasmodium falciparum erythrocytic schizonts: stimulation by cytokines and inhibition by neomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Human lymphokine-activated killer cells are cytotoxic against cells infected with Toxoplasma gondii

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Lysis of murine macrophages infected with intracellular pathogens by interleukin 2-activated killer (LAK) cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

The beige mutation in the mouse selectively impairs natural killer cell function

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Murine malaria: dissociation of natural killer (NK) cell activity and resistance to Plasmodium chabaudi.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Apparent irrelevance of NK cells to resolution of infections with Babesia microti and Plasmodium vinckei petteri in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

A possible role for natural killer cells in providing protection against Plasmodium berghei in early stages of infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Experimental Cryptosporidium parvum infections in immunosuppressed adult mice

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Comparison of four murine Eimeria species in immunocompetent and immunodeficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Clearance of Giardia muris infection in mice deficient in natural killer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Emergence of NK1.1+ cells as effectors of IFN-gamma dependent immunity to Toxoplasma gondii in MHC class I-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Early parasite containment is decisive for resistance to Leishmania major infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Reconstitution of C.B-17 scid mice with BALB/c T cells initiates a T helper type-1 response and renders them capable of healing Leishmania major infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Role of IL12 in induction of cell-mediated immunity to Toxoplasma gondii.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: role of NK cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Role of T helper/inducer cells as well as natural killer cells in resistance to Trypanosoma cruzi infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Interleukin-12-mediated resistance to Trypanosoma cruzi is dependent on tumor necrosis factor alpha and gamma interferon.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Interleukin 12 induction of interferon gamma-dependent protection against malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Mechanisms of innate and acquired resistance to Cryptosporidium parvum infection in SCID mice

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Human natural killer cells produce abundant macrophage inflammatory protein-1 alpha in response to monocyte-derived cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Molecular and cellular basis of interleukin 12 activity in prophylaxis and therapy against infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Natural and acquired resistance to Leishmania: cellular activation by Leishmania aethiopica of mononuclear cells from unexposed individuals is through the stimulation of natural killer (NK) cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Cytotoxicity in human mucosal and cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Enhancement of human natural killer cell activity by subcellular components of Toxoplasma gondii.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

A monoclonal antibody that recognizes phosphatidylinositol inhibits induction of tumor necrosis factor alpha by different strains of Plasmodium falciparum.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Glycosylphosphatidylinositol toxin of Trypanosoma brucei regulates IL-1 alpha and TNF-alpha expression in macrophages by protein tyrosine kinase mediated signal transduction.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Biochemical characterization and protein kinase C dependency of monokine-inducing activities of Toxoplasma gondii

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

CR3-dependent resistance to acute Toxoplasma gondii infection in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Effects of IL-12 on immune responses to microbial infections: a key mediator in regulating disease outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Cloning of a new cytokine that induces IFN-gamma production by T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Mapping of the epitope recognized by non-specific cytotoxic cells: determination of the fine specificity using synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Recognition events that inhibit and activate natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Transforming growth factor-beta inhibits interleukin-12-induced production of interferon-gamma by natural killer cells: a role for transforming growth factor-beta in the regulation of T cell-independent resistance to Toxoplasma gondii.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Recombinant interleukin 12 cures mice infected with Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin 12 and Pentostam

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

The adjuvant effect of interleukin-12 in a vaccine against Leishmania major.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980157-4

7 January 2021

10.1016/S0952-7915(97)80157-4

Identifiers

DOI

1 reference

release_zgq6fagfcnfc5fuwxhylicienm

29 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zgq6fagfcnfc5fuwxhylicienm

24 November 2022

mapped directly with Wikidata item

PubMed ID

9039777

1 reference

PubMed ID

9039777